Rhumbline Advisers Lian Bio Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
A detailed history of Rhumbline Advisers transactions in Lian Bio stock. As of the latest transaction made, Rhumbline Advisers holds 125,457 shares of LIAN stock, worth $38,891. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,457Holding current value
$38,891% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LIAN
# of Institutions
4Shares Held
1.09MCall Options Held
0Put Options Held
0About LianBio
- Ticker LIAN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,354,000
- Market Cap $33.6M
- Description
- LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...